NASDAQ : ELDN

Eledon Pharmaceuticals, Inc.

$4.07 USD

$0.23 (5.99%)

Volume
787.62K
Average Volume
1.45M
Market Capitalization
$243.99M
P/E Ratio
-4.68
Dividend Yield
0.00%
Price Target
$5.00
Year High
$4.60
Year Low
$1.35
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$8.44
3333332"{? p/.m7yd f,0=

Annual earnings financials

ELDN financial data with annual/quarterly toggle

ELDN GAAP EPS - Annual & Quarterly

ELDN Sales Revenue - Annual & Quarterly

ELDN Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ELDN Estimated and Actual Revenue by Quarter
ELDN Estimated and Actual EPS by Quarter
ELDN Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
ELDN Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 0 -24.17M -24.17M -24.17M - - -
2027-09-30 0 -23.61M -23.61M -23.61M - - -
2027-06-30 0 -25.3M -25.3M -25.3M - - -
2027-03-31 0 -23.61M -23.61M -23.61M - - -
2026-12-31 0 -21.14M -21.14M -21.14M - - -
2026-09-30 0 -20.91M -20.91M -20.91M - - -
ELDN Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 0 - - - 1 -0.215 -0.215 -0.215
2027-09-30 0 - - - 1 -0.21 -0.21 -0.21
2027-06-30 0 - - - 1 -0.225 -0.225 -0.225
2027-03-31 0 - - - 1 -0.21 -0.21 -0.21
2026-12-31 0 - - - 1 -0.188 -0.188 -0.188
2026-09-30 0 - - - 2 -0.186 -0.186 -0.186